Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity

Acta Trop. 2018 Aug:184:38-52. doi: 10.1016/j.actatropica.2017.09.017. Epub 2017 Sep 21.

Abstract

The genetic diversity of Trypanosoma cruzi, the protozoan agent of Chagas disease, is widely recognized. At present, T. cruzi is partitioned into seven discrete typing units (DTUs), TcI-TcVI and Tcbat. This article reviews the present knowledge on the parasite population structure, the evolutionary relationships among DTUs and their distinct, but not exclusive ecological and epidemiological associations. Different models for the origin of hybrid DTUs are examined, which agree that genetic exchange among T. cruzi populations is frequent and has contributed to the present parasite population structure. The geographic distribution of the prevalent DTUs in humans from the southern United States to Argentina is here presented and the circumstantial evidence of a possible association between T. cruzi genotype and Chagas disease manifestations is discussed. The available information suggests that parasite strains detected in patients, regardless of the clinical presentation, reflect the principal DTU circulating in the domestic transmission cycles of a particular region. In contrast, in several orally transmitted outbreaks, sylvatic strains are implicated. As a consequence of the genotypic and phenotypic differences of T. cruzi strains and the differential geographic distribution of DTUs in humans, regional variations in the sensitivity of the serological tests are verified. The natural resistance to benznidazole and nifurtimox, verified in vivo and in vitro for some parasite stocks, is not associated with any particular DTU, and does not explain the marked difference in the anti-parasitic efficacy of both drugs in the acute and chronic phases of Chagas disease. Throughout this review, it is emphasized that the interplay between parasite and host genetics should have an important role in the definition of Chagas disease pathogenesis, anti-T. cruzi immune response and chemotherapy outcome and should be considered in future investigations.

Keywords: Chagas disease pathology; Chemotherapy; Hybridization; Serological diagnosis; Trypanosoma cruzi discrete typing units; immune response.

Publication types

  • Review

MeSH terms

  • Animals
  • Argentina
  • Biological Evolution
  • Chagas Disease / drug therapy*
  • Chagas Disease / genetics*
  • Chagas Disease / transmission
  • Drug Resistance / genetics*
  • Genetic Variation
  • Genotype
  • Humans
  • Nifurtimox / therapeutic use*
  • Nitroimidazoles / therapeutic use*
  • Serologic Tests / methods*
  • Trypanosoma cruzi / genetics*

Substances

  • Nitroimidazoles
  • Nifurtimox
  • benzonidazole